Cargando…
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council
BACKGROUND: Assessment of chronic hand eczema (CHE) is complex and warrants standardization. OBJECTIVE: We sought to guide clinicians on the assessment of CHE. METHODS: An electronic questionnaire regarding the diagnosis and assessment of CHE was completed by councilors (n=45) of the International E...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437046/ https://www.ncbi.nlm.nih.gov/pubmed/32991335 http://dx.doi.org/10.1097/DER.0000000000000659 |
_version_ | 1783752096856670208 |
---|---|
author | Silverberg, Jonathan I. Guttman-Yassky, Emma Agner, Tove Bissonnette, Robert Cohen, David E. Simpson, Eric Wollenberg, Andreas Thyssen, Jacob P. |
author_facet | Silverberg, Jonathan I. Guttman-Yassky, Emma Agner, Tove Bissonnette, Robert Cohen, David E. Simpson, Eric Wollenberg, Andreas Thyssen, Jacob P. |
author_sort | Silverberg, Jonathan I. |
collection | PubMed |
description | BACKGROUND: Assessment of chronic hand eczema (CHE) is complex and warrants standardization. OBJECTIVE: We sought to guide clinicians on the assessment of CHE. METHODS: An electronic questionnaire regarding the diagnosis and assessment of CHE was completed by councilors (n=45) of the International Eczema Council, an international group of clinicians and researchers with expertise in CHE. The survey consisted of 52 statements for consensus. RESULTS: Overall, nine statements (17.3%) had strong, twenty-three (44.2%) moderate, 12 (23.1%) low, and 8 (15.4%) very low levels of agreement. Five statements had considerable disagreement, including the value of conducting a skin biopsy (62.2% disagreement), investigating for possible type 1 reactions (60.0%), conducting a fungal culture (44.4%), finding no history of relevant allergens and/or irritants (31.1%) in most or all cases, and performing patch testing irrespective of lesion location and morphology (28.9%). Agreement was generally highest among respondents from Europe (28.6–77.8% agreement), followed by Asia (7.1%–35.7% agreement), North America (0%–35.5% agreement), and other (0%–13.3% agreement). CONCLUSIONS: There were substantial differences of agreement, suggesting there are many knowledge and/or practice gaps with respect to CHE. Future research is needed to inform evidence-based and/or consensus guidelines for CHE. |
format | Online Article Text |
id | pubmed-8437046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-84370462021-09-20 Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council Silverberg, Jonathan I. Guttman-Yassky, Emma Agner, Tove Bissonnette, Robert Cohen, David E. Simpson, Eric Wollenberg, Andreas Thyssen, Jacob P. Dermatitis Studies BACKGROUND: Assessment of chronic hand eczema (CHE) is complex and warrants standardization. OBJECTIVE: We sought to guide clinicians on the assessment of CHE. METHODS: An electronic questionnaire regarding the diagnosis and assessment of CHE was completed by councilors (n=45) of the International Eczema Council, an international group of clinicians and researchers with expertise in CHE. The survey consisted of 52 statements for consensus. RESULTS: Overall, nine statements (17.3%) had strong, twenty-three (44.2%) moderate, 12 (23.1%) low, and 8 (15.4%) very low levels of agreement. Five statements had considerable disagreement, including the value of conducting a skin biopsy (62.2% disagreement), investigating for possible type 1 reactions (60.0%), conducting a fungal culture (44.4%), finding no history of relevant allergens and/or irritants (31.1%) in most or all cases, and performing patch testing irrespective of lesion location and morphology (28.9%). Agreement was generally highest among respondents from Europe (28.6–77.8% agreement), followed by Asia (7.1%–35.7% agreement), North America (0%–35.5% agreement), and other (0%–13.3% agreement). CONCLUSIONS: There were substantial differences of agreement, suggesting there are many knowledge and/or practice gaps with respect to CHE. Future research is needed to inform evidence-based and/or consensus guidelines for CHE. Lippincott Williams & Wilkins 2021 2020-09-28 /pmc/articles/PMC8437046/ /pubmed/32991335 http://dx.doi.org/10.1097/DER.0000000000000659 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Contact Dermatitis Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Studies Silverberg, Jonathan I. Guttman-Yassky, Emma Agner, Tove Bissonnette, Robert Cohen, David E. Simpson, Eric Wollenberg, Andreas Thyssen, Jacob P. Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title | Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title_full | Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title_fullStr | Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title_full_unstemmed | Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title_short | Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council |
title_sort | chronic hand eczema guidelines from an expert panel of the international eczema council |
topic | Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437046/ https://www.ncbi.nlm.nih.gov/pubmed/32991335 http://dx.doi.org/10.1097/DER.0000000000000659 |
work_keys_str_mv | AT silverbergjonathani chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT guttmanyasskyemma chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT agnertove chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT bissonnetterobert chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT cohendavide chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT simpsoneric chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT wollenbergandreas chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil AT thyssenjacobp chronichandeczemaguidelinesfromanexpertpaneloftheinternationaleczemacouncil |